Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
  • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
  • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
  • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
  • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
  • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
  • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • A61K38/22—Hormones
  • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/02—Inorganic compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
  • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
  • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/08—Solutions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
  • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P5/00—Drugs for disorders of the endocrine system
  • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Endocrinology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Reproductive Health (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Immunology (AREA)
• Dermatology (AREA)
• Zoology (AREA)
• Gastroenterology & Hepatology (AREA)
• Molecular Biology (AREA)
• Biochemistry (AREA)
• Organic Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Inorganic Chemistry (AREA)
• Diabetes (AREA)
• Pregnancy & Childbirth (AREA)
• Gynecology & Obstetrics (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Medicinal Preparation (AREA)
• Medical Preparation Storing Or Oral Administration Devices (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=40568186

Family Applications (1)

Country Status (27)

Families Citing this family (21)

Family Cites Families (19)

• 2009
  • 2009-02-09 WO PCT/EP2009/051451 patent/WO2009098318A1/en active Application Filing
  • 2009-02-09 CA CA2926500A patent/CA2926500A1/en not_active Abandoned
  • 2009-02-09 ME MEP-2011-182A patent/ME01337B/me unknown
  • 2009-02-09 CA CA2713386A patent/CA2713386C/en not_active Expired - Fee Related
  • 2009-02-09 EA EA201070940A patent/EA019530B1/ru not_active IP Right Cessation
  • 2009-02-09 JP JP2010545495A patent/JP5620824B2/ja active Active
  • 2009-02-09 PL PL09708298T patent/PL2249869T3/pl unknown
  • 2009-02-09 PT PT09708298T patent/PT2249869E/pt unknown
  • 2009-02-09 US US12/866,736 patent/US20110054410A1/en not_active Abandoned
  • 2009-02-09 DE DE202009009905U patent/DE202009009905U1/de not_active Expired - Lifetime
  • 2009-02-09 RS RS20110505A patent/RS52106B/en unknown
  • 2009-02-09 AU AU2009211331A patent/AU2009211331B2/en active Active
  • 2009-02-09 MX MX2010008802A patent/MX2010008802A/es unknown
  • 2009-02-09 EP EP11179767A patent/EP2412385A1/de not_active Withdrawn
  • 2009-02-09 CN CN2009801040855A patent/CN101970010A/zh active Pending
  • 2009-02-09 BR BRPI0908887A patent/BRPI0908887B8/pt active IP Right Grant
  • 2009-02-09 ES ES09708298T patent/ES2372470T3/es active Active
  • 2009-02-09 KR KR1020107018371A patent/KR101573773B1/ko active Active
  • 2009-02-09 KR KR1020157033736A patent/KR101662631B1/ko active Active
  • 2009-02-09 DK DK09708298.6T patent/DK2249869T3/da active
  • 2009-02-09 CN CN201510082820.4A patent/CN104688679A/zh active Pending
  • 2009-02-09 SI SI200930091T patent/SI2249869T1/sl unknown
  • 2009-02-09 UA UAA201010809A patent/UA99337C2/ru unknown
  • 2009-02-09 NZ NZ586588A patent/NZ586588A/xx not_active IP Right Cessation
  • 2009-02-09 AT AT09708298T patent/ATE523209T1/de active
  • 2009-02-09 EP EP09708298A patent/EP2249869B1/de active Active
  • 2009-02-09 CN CN201910216104.9A patent/CN110433136A/zh active Pending
• 2010
  • 2010-06-24 ZA ZA2010/04457A patent/ZA201004457B/en unknown
  • 2010-07-01 IL IL206759A patent/IL206759A/en active IP Right Grant
• 2011
  • 2011-04-13 HK HK11103750.1A patent/HK1149494A1/xx not_active IP Right Cessation
  • 2011-11-02 HR HR20110801T patent/HRP20110801T1/hr unknown
  • 2011-11-24 CY CY20111101150T patent/CY1112082T1/el unknown
• 2016
  • 2016-06-29 US US15/196,460 patent/US20160303202A1/en not_active Abandoned
  • 2016-06-29 US US15/196,430 patent/US20160303201A1/en not_active Abandoned
  • 2016-06-29 US US15/196,440 patent/US20160303238A1/en not_active Abandoned

Also Published As

Similar Documents

Legal Events